Bortezomib-Induced Reticular Eruption in Patient with Multiple Myeloma

Bortezomib is the first proteasome inhibitor to treat a variety of malignancies and is currently part of the standard of care regimen for the initial treatment of patients with newly diagnosed multiple myeloma. While bortezomib is generally well tolerated, it has been associated with various side ef...

Full description

Saved in:
Bibliographic Details
Main Authors: Joseph Han (Author), Shayan Owji (Author), Aneesh Agarwal (Author), Samir Kamat (Author), Yen Luu (Author), Adnan Mubasher (Author), George Niedt (Author), Chloe Ray (Author), Hearn Jay Cho (Author), Nicholas Gulati (Author), Angela Lamb (Author)
Format: Book
Published: MDPI AG, 2023-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!